Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
04/2004
04/28/2004EP1411935A1 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
04/28/2004EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/28/2004EP1313724B1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents
04/28/2004EP1263718B1 Novel use of phenylheteroalkylamine derivatives
04/28/2004EP1263714B1 Novel phenylheteroalkylamine derivatives
04/28/2004EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
04/28/2004EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
04/28/2004EP0881267B1 Azo compounds and process for preparing the same
04/28/2004EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them
04/28/2004CN1492762A Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators
04/28/2004CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them
04/27/2004US6727367 Quaternizing pramipexole into optical isomers via reacting monobasic acid addition salt with optically active acid forming diastereomeric mixed salts and precipitating from solvent to form separated diastereomers
04/27/2004US6727271 Oxazole or thiazole derivatives; antilipemic agents, hypotensives, antineoplastic agents
04/27/2004US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding
04/27/2004US6727268 Cyclooxygenase inhibitors; antipyretic, analgesic, antiinflammatory, and anticarcinogenic agents
04/27/2004US6727267 NS5B HVC polymerase inhibitors
04/27/2004US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders
04/27/2004US6727238 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
04/27/2004US6727041 Optical recording media
04/22/2004WO2004033652A2 Inhibitors of fatty acid amide hydrolase
04/22/2004WO2004033439A1 Thiazole compounds for the treatment of neurodegenerative disorders
04/22/2004WO2004033438A1 Novel heterocyclic analogs of diphenylethylene compounds
04/22/2004WO2004033423A2 Anticancer compounds
04/22/2004WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
04/22/2004WO2004032931A1 Method for treatment of cancer
04/22/2004WO2004014852A3 Iminothiazolidinones as inhibitors of hcv replication
04/22/2004WO2003041728A9 Novel phenyl-propargylether derivatives
04/22/2004WO2002074752A8 Metalloproteinase inhibitors
04/22/2004US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer
04/22/2004US20040077867 Amine compounds, their production and use
04/22/2004US20040077846 Dispers-reactive dyes containing acetoxymethylsulfone or vinylsulfone and their process
04/22/2004US20040077697 2-Acylaminothiazole derivative or its salt
04/22/2004US20040077696 Heterocyclic inhibitors of kinases
04/22/2004US20040077695 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases
04/22/2004US20040077691 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
04/22/2004US20040077646 Indole nitriles
04/22/2004US20040077633 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus
04/22/2004US20040077613 Stimulation of preadipocyte differentiation; insulin resis-tance syndrome, dyslipidemia, type 2 diabetes; LXR alpha receptor agonists
04/22/2004US20040077525 Novel treatment
04/22/2004DE10246959A1 New N-biphenyl thiazole-5-carboxamide derivatives, useful as antimicrobials for the protection of plants and technical materials, e.g. wood, against bacteria, fungi and algae
04/22/2004CA2501901A1 Anticancer compounds
04/22/2004CA2501803A1 Thiazole compounds for the treatment of neurodegenerative disorders
04/22/2004CA2501575A1 Inhibitors of fatty acid amide hydrolase
04/22/2004CA2501456A1 Novel heterocyclic analogs of diphenylethylene compounds
04/21/2004EP1411049A1 Estrogen Agonists/Antagonists
04/21/2004EP1410822A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents
04/21/2004EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1409440A1 A method to inhibit ethylene responses in plants
04/21/2004EP1311160A4 2-phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491218A Method for preparing compounds derived from thiazolidinedione, oxazolidinedione
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1146575C Peptidyl heterocycles useful in the treatment of thrombin related disorders
04/21/2004CN1146536C Cycloethylene derivatives
04/21/2004CN1146535C Preparing method for azide derivatives
04/20/2004USRE38506 Potent inducers of terminal differentiation and methods of use thereof
04/20/2004US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723741 Benzimidazoles and benzothiazoles and uses thereof
04/20/2004US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides
04/20/2004CA2215585C Practical synthesis of urea derivatives
04/15/2004WO2004031163A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-SUBSTITUTED CYSTEINE OR SALT THEREOF, INTERMEDIATE THEREFOR, AND PROCESS FOR PRODUCING THE SAME
04/15/2004WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/15/2004WO2004031138A1 Novel sulphones for inhibition of gamma secretase
04/15/2004WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
04/15/2004WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
04/15/2004WO2003045324A3 14-methyl-epothilones
04/15/2004WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
04/15/2004US20040073029 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors
04/15/2004US20040073026 Cyclic protein tyrosine kinase inhibitors
04/15/2004US20040072881 Dietetics; osteoporosis; muscular disorders
04/15/2004US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders
04/15/2004US20040072838 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
04/15/2004US20040072827 Antiinflammatory agents; antiallergens; autoimmune diseases
04/15/2004US20040072826 Organic compound having cyano group and insecticides/miticides
04/15/2004US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases
04/15/2004US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8
04/15/2004US20040072252 Heteroaryl substituted benzothiazole dioxetanes
04/15/2004CA2500969A1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/15/2004CA2500966A1 Novel sulphones for inhibition of gamma secretase
04/14/2004EP1406899A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
04/14/2004EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
04/14/2004EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin
04/14/2004EP1406883A1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
04/14/2004EP1406882A1 Supported condensation reactants and method for the production thereof
04/14/2004EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/14/2004EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
04/14/2004EP1406858A1 Substituted 4-aminocyclohexanols
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/14/2004EP1406620A1 Vinyl phenyl derivatives as glk activators
04/14/2004EP1406617A1 Diaminediols for the treatment of alzheimer's disease
04/14/2004EP1406605A1 Carbamates of 2-heterocyclic-1,2-ethanediols
04/14/2004EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands
04/14/2004EP1102757B1 Substituted oxazole and thiazole derivatives as hppar gamma and hppar alpha activators
04/14/2004CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes
04/14/2004CN1489582A Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient
04/14/2004CN1489577A Cyanothioacetamide derivatives and process for preparing same
04/14/2004CN1489458A Inhibitors against the production and releaseof inflammator cytokines